[HTML][HTML] Tumor markers of breast cancer: New prospectives

AM Kabel - Journal of Oncological Sciences, 2017 - Elsevier
Tumor markers are substances produced by the tumors or by other cells of the body in
response to cancer or certain benign conditions. Although most of these markers are made …

Plasmin and plasminogen system in the tumor microenvironment: implications for cancer diagnosis, prognosis, and therapy

AG Bharadwaj, RW Holloway, VA Miller, DM Waisman - Cancers, 2021 - mdpi.com
Simple Summary In this review, we present a detailed discussion of how the plasminogen-
activation system is utilized by tumor cells in their unrelenting attack on the tissues …

Evolving role of uPA/uPAR system in human cancers

K Dass, A Ahmad, AS Azmi, SH Sarkar… - Cancer treatment …, 2008 - Elsevier
Recent advancements in cancer research have led to some major breakthroughs; however,
the impact on overall cancer-related death rate remains unacceptable, suggesting that …

The urokinase plasminogen activator system in breast cancer invasion and metastasis

L Tang, X Han - Biomedicine & Pharmacotherapy, 2013 - Elsevier
The urokinase plasminogen activator system, which is a serine protease family include
urokinase-type plasminogen activator (uPA), the uPA receptor and plasminogen activator …

Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression

V Nikolova, CY Koo, SA Ibrahim, Z Wang… - …, 2009 - academic.oup.com
The heparan sulfate proteoglycan syndecan-1 (Sdc1) modulates cell proliferation, adhesion,
migration and angiogenesis. Proteinase-mediated shedding converts Sdc1 from a …

Structure and function of plasminogen/plasmin system

RB Aisina, LI Mukhametova - Russian Journal of Bioorganic Chemistry, 2014 - Springer
The main physiological function of plasmin is blood clot fibrinolysis and restoration of normal
blood flow. To date, however, it became apparent that in addition to thrombolysis, the …

The urokinase plasminogen activation system in pancreatic cancer: prospective diagnostic and therapeutic targets

AA Kumar, BJ Buckley, M Ranson - Biomolecules, 2022 - mdpi.com
Pancreatic cancer is a highly aggressive malignancy that features high recurrence rates and
the poorest prognosis of all solid cancers. The urokinase plasminogen activation system …

From plasminogen to plasmin: role of plasminogen receptors in human cancer

M Didiasova, L Wujak, M Wygrecka… - International Journal of …, 2014 - mdpi.com
Cell surface-associated proteolysis mediated by plasmin (PLA) is an essential feature of
wound healing, angiogenesis and cell invasion, processes that are dysregulated in cancer …

The urokinase plasminogen activator system in human cancers: an overview of its prognostic and predictive role

J Madunić - Thrombosis and haemostasis, 2018 - thieme-connect.com
Urokinase plasminogen activator (uPA) system regulates extracellular matrix remodelling by
activating ubiquitous protease plasmin in many important physiological processes. The …

So many plasminogen receptors: why?

EF Plow, L Doeuvre, R Das - BioMed Research International, 2012 - Wiley Online Library
Plasminogen and plasmin tether to cell surfaces through ubiquitously expressed and
structurally quite dissimilar family of proteins, as well as some nonproteins, that are …